Update on Long-Acting Anticholinergics in Children and Adolescents With Difficult and Severe Asthma

• Hlavní autoři: Francesca Santamaria (Autor), Carla Ziello (Autor), Paola Lorello (Autor), Cristina Bouchè (Autor), Melissa Borrelli (Autor)
• Médium: Kniha
• Vydáno: Frontiers Media S.A., 2022-07-01T00:00:00Z.
• Témata: article
• On-line přístup: Connect to this object online.

Tiotropium bromide is the only long-acting muscarinic antagonist (LAMA) approved for treatment of patients aged ≥6 years old who have symptoms of uncontrolled asthma. Results from several clinical trials have found that once-daily inhaled tiotropium bromide is safe and efficacious in 6- to 17-year-o...